Atreca Announces Appointment of Dr. Lindsey Rolfe to its Board of Directors
August 26, 2019 16:05 ET
|
Atreca, Inc.
REDWOOD CITY, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of the...
Atreca Reports Second Quarter 2019 Financial Results and Recent Corporate Developments
August 13, 2019 16:05 ET
|
Atreca, Inc.
REDWOOD CITY, Calif., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of the...
Atreca Further Strengthens Management Team with Appointment of Lisa Decker as Chief Business Officer and Courtney Phillips as General Counsel
July 11, 2019 08:00 ET
|
Atreca, Inc.
REDWOOD CITY, Calif., July 11, 2019 (GLOBE NEWSWIRE) -- Atreca, Inc. (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human...
Atreca Announces Pricing of Initial Public Offering
June 19, 2019 21:40 ET
|
Atreca, Inc.
REDWOOD CITY, Calif., June 19, 2019 (GLOBE NEWSWIRE) -- Atreca, Inc. (Nasdaq: BCEL), a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based...